secwatch.observer — SEC 8-K summary
======================================

Issuer:     DiaMedica Therapeutics Inc. (DMAC)
CIK:        0001401040
Form:       8-K
Filed at:   2025-03-06T23:59:59+00:00
Accession:  0001437749-25-006379
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director Richard Pilnik to retire from DiaMedica board at 2025 AGM
------------------------------------------------------------------

- Richard Pilnik, director for over 15 years, will retire and not stand for re-election at the 2025 AGM, effective May 15, 2025.
- His decision is not due to any disagreement with the company on operations, policies, or practices.
- Chairman role already transitioned to James Parsons; board also recently added Daniel O'Connor as new director.
- Board to re-evaluate committee composition and chair roles after Pilnik's departure for seamless transition.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1401040/000143774925006379/0001437749-25-006379-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1401040/000143774925006379/dmtp20250305_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-006379

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer